Meeting of the Regional MDR-TB Advisory Committee on "Ending MDR-TB in the South-East Asia Region", 25-26 February 2019 and Stakeholders consultation on tools for community engagement for MDR-TB services, 27-28 February 2019, Dhaka, Bangladesh
The South-East Asia Regional office of WHO organised two back-to-back meetings towards end of February in Dhaka, Bangladesh. The first one was the Regional Green Light Committee (rGLC) meeting and the second one was Stakeholders’ consultation on tools for strengthening community engagement in MDR-TB services. The Regional Advisory Committee on MDR-TB in the WHO South-East Asia Region, also known as the Regional Green Light Committee (rGLC) is an advisory body to the Regional Director. The committee provides guidance on new policies and strategies and implementation of programmatic management of drug-resistant TB. The rGLC meeting titled “Ending MDR-TB in the South-East Asia Region” from 25 to 26 February 2019 was the 11th rGLC meeting and first of the reconstituted committee. The second meeting was focussed on strengthening community engagement in MDR-TB services. Community capacity in the South-East Asia Region of WHO to meaningfully engage with national programmes in delivery and monitoring for DR-TB services is one of the key gap area as identified by the rGLC in its meeting held in January 2018. With an aim to develop tools for community capacity building in DR-TB, WHO engaged with community representatives for the development training modules for the community members.
Workshop on transition plan for implementation of updated WHO guidance for the management of drug-resistant and management of latent TB infection, 12-14 December 2018, New Delhi, India
The South-East Asia Regional office of World Health Organization organized a workshop of Member States and key partners on preparing a transition plan for implementation of updated WHO guidance for the management of drug-resistant and management of latent TB infection, in New Delhi, India from 12 – 14 December 2018. The general objective of the workshop was to provide technical support to Member States in planning transition to newer RR/MDR-TB regimen and rolling out LTBI guidelines in the Region. The workshop was attended by national programme managers of Member States, heads of WHO Collaborating Centres for Training and Research in Tuberculosis, key donors and partners, civil society representatives and WHO staff from HQ, country offices and regional office. This platform gave an opportunity to share the country level progress towards achieving targets for ending TB. During the workshop, participants developed an outline of action plan with timelines for adopting the new guidelines in their respective countries.
Delhi End TB Summit 2018, 13-14 March 2018, New Delhi, India
The World Health Organization along with the Ministry of Health & Family Welfare, Govt of India, Stop TB Partnership and other partners organized a multicountry multiagency TB Summit in Delhi from 13-14 March 2018.
The meeting was also aimed to track progress to eliminate tuberculosis as the Member countries of WHO South-East Asia Region are committed to further intensify efforts to ensure rapid and concrete progress to End TB by 2030.
The inaugural session was held on 13 March at Vigyan Bhawan, Delhi and attended by Prime Minister of India along with cabinet and State Ministers of Health and Family Welfare. Other dignitaries gracing the occasion were Health Ministers from Indonesia and Nigeria, DG WHO, Regional Director WHO SEARO, Executive Director Stop TB Partnership and Executive Director, Global Fund. Prime Minister of India launched the TB free India Campaign and committed to end TB in the country by 2025.
Ministerial Meeting towards Ending TB in the South-East Asia, 15-16 March 2017, New Delhi, India
The South East Asia (SEA) Region of WHO is home to one fourth of the world’s population; however the region accounts for nearly half of the global burden in terms of new TB cases appearing each year. In 2015, there were an estimated 4.74 million new cases of TB and nearly 800 000 people died due to TB (and TB-HIV) in the Region. Total number of new cases notified to National TB programs of the SEA Region were only about 54% of the new cases. Six SEAR Member States are in the list of 30 high TB burden countries globally- Bangladesh, DPR Korea, India, Indonesia, Myanmar and Thailand. The estimated incidence of multi-drug-resistant and rifampicin resistant (MDR/RR-TB) in the Region is 200,000 out of which only 32,648 were started on treatment in 2015 or just around 16% of the incident cases. Extensively drug resistant TB had been reported by 6 countries in SEAR by 2015. An estimated 227,000 cases (4.7%) of the 4.7 million incident cases were HIV positive. With current level of efforts, the Region is achieving only 1.5-2% annual decline in incidence of TB which is grossly insufficient compared to the required decline of at least 10-15% if we are to reach the WHO End TB Strategy targets (aligned with the SDG goals).
TB burden, 2016
~45%The proportion of the global TB incidence in the RegionRefer to pie chart
TB Mortality, 2016
>650 000 TB deaths
and additional 35 000 deaths from TB-HIV coinfection in the Region
MDR/RR-TB incidence, 2016
>30%The proportion of global estimates multidrug-resistant/rifampicin-resistant new cases from the RegionRefer to regional update 2016